Published in Mol Microbiol on June 01, 2007
Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol (2009) 7.89
Toxin B is essential for virulence of Clostridium difficile. Nature (2009) 5.49
Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol (2009) 3.66
Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol (2010) 2.29
Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One (2011) 2.04
Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1. J Clin Microbiol (2008) 1.98
The PlcR virulence regulon of Bacillus cereus. PLoS One (2008) 1.89
Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev (2013) 1.85
Morphological and genetic diversity of temperate phages in Clostridium difficile. Appl Environ Microbiol (2007) 1.71
Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother (2008) 1.71
Precise manipulation of the Clostridium difficile chromosome reveals a lack of association between the tcdC genotype and toxin production. Appl Environ Microbiol (2012) 1.70
Importance of prophages to evolution and virulence of bacterial pathogens. Virulence (2013) 1.48
Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006. J Clin Microbiol (2008) 1.47
Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes. J Clin Microbiol (2011) 1.37
The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile. J Bacteriol (2011) 1.30
The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS Pathog (2011) 1.28
Global transcriptional control by glucose and carbon regulator CcpA in Clostridium difficile. Nucleic Acids Res (2012) 1.25
Microarray identification of Clostridium difficile core components and divergent regions associated with host origin. J Bacteriol (2009) 1.24
Clostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions. Gut Microbes (2010) 1.19
Evolutionary history of the Clostridium difficile pathogenicity locus. Genome Biol Evol (2014) 1.16
Secretion of Clostridium difficile toxins A and B requires the holin-like protein TcdE. PLoS Pathog (2012) 1.12
Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens. J Bacteriol (2011) 1.10
Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A. BMC Infect Dis (2009) 1.10
Proline-dependent regulation of Clostridium difficile Stickland metabolism. J Bacteriol (2012) 1.09
Bacteriophage-mediated toxin gene regulation in Clostridium difficile. J Virol (2009) 1.09
Clostridium difficile infection in the twenty-first century. Emerg Microbes Infect (2013) 1.09
Bench-to-bedside review: Clostridium difficile colitis. Crit Care (2008) 1.08
Both, toxin A and toxin B, are important in Clostridium difficile infection. Gut Microbes (2011) 1.06
TcdC does not significantly repress toxin expression in Clostridium difficile 630ΔErm. PLoS One (2012) 1.02
The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD. J Bacteriol (2013) 1.00
Variations in virulence and molecular biology among emerging strains of Clostridium difficile. Microbiol Mol Biol Rev (2013) 0.99
C. difficile 630Δerm Spo0A regulates sporulation, but does not contribute to toxin production, by direct high-affinity binding to target DNA. PLoS One (2012) 0.98
Multiplex PCR method for detection of Clostridium difficile tcdA, tcdB, cdtA, and cdtB and internal in-frame deletion of tcdC. J Clin Microbiol (2011) 0.96
Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR. Eur J Clin Microbiol Infect Dis (2011) 0.96
Genetic relatedness of Clostridium difficile isolates from various origins determined by triple-locus sequence analysis based on toxin regulatory genes tcdC, tcdR, and cdtR. J Clin Microbiol (2008) 0.96
Diversity and Evolution in the Genome of Clostridium difficile. Clin Microbiol Rev (2015) 0.94
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile. Annu Rev Microbiol (2015) 0.93
Modulation of toxin production by the flagellar regulon in Clostridium difficile. Infect Immun (2012) 0.92
Integration of metabolism and virulence in Clostridium difficile. Res Microbiol (2014) 0.92
Toxin synthesis by Clostridium difficile is regulated through quorum signaling. MBio (2015) 0.91
Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol (2016) 0.90
Characterization of the SigD regulon of C. difficile and its positive control of toxin production through the regulation of tcdR. PLoS One (2013) 0.89
Clostridium difficile: New Insights into the Evolution of the Pathogenicity Locus. Sci Rep (2015) 0.88
Effects of subinhibitory concentrations of antibiotics on colonization factor expression by moxifloxacin-susceptible and moxifloxacin-resistant Clostridium difficile strains. Antimicrob Agents Chemother (2009) 0.87
The enteropathogenic Escherichia coli effector NleH inhibits apoptosis induced by Clostridium difficile toxin B. Microbiology (2010) 0.87
CdtR Regulates TcdA and TcdB Production in Clostridium difficile. PLoS Pathog (2016) 0.87
A multiplex, internally controlled real-time PCR assay for detection of toxigenic Clostridium difficile and identification of hypervirulent strain 027/ST-1. Eur J Clin Microbiol Infect Dis (2011) 0.87
Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen. Gut Microbes (2014) 0.86
Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile. Antimicrob Agents Chemother (2008) 0.86
Emergence of an outbreak-associated Clostridium difficile variant with increased virulence. J Clin Microbiol (2015) 0.85
Review of medical and surgical management of Clostridium difficile infection. Tech Coloproctol (2010) 0.85
The potential for emerging therapeutic options for Clostridium difficile infection. Gut Microbes (2014) 0.84
Hype or hypervirulence: a reflection on problematic C. difficile strains. Virulence (2013) 0.83
Genotypic investigation of Clostridium difficile in Prince Edward Island. Can J Infect Dis Med Microbiol (2008) 0.82
Clostridium difficile TcdC protein binds four-stranded G-quadruplex structures. Nucleic Acids Res (2013) 0.82
In vivo lysogenization of a Clostridium difficile bacteriophage ФCD119. Anaerobe (2011) 0.81
Mathematical modelling reveals properties of TcdC required for it to be a negative regulator of toxin production in Clostridium difficile. J Math Biol (2014) 0.79
Using phenotype microarrays to determine culture conditions that induce or repress toxin production by Clostridium difficile and other microorganisms. PLoS One (2013) 0.79
Time-resolved amino acid uptake of Clostridium difficile 630Δerm and concomitant fermentation product and toxin formation. BMC Microbiol (2015) 0.79
Observations on the Role of TcdE Isoforms in Clostridium difficile Toxin Secretion. J Bacteriol (2015) 0.78
The Regulatory Networks That Control Clostridium difficile Toxin Synthesis. Toxins (Basel) (2016) 0.78
Exposing the secrets of two well-known Lactobacillus casei phages, J-1 and PL-1, by genomic and structural analysis. Appl Environ Microbiol (2014) 0.78
Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects. Toxins (Basel) (2016) 0.77
Control of Clostridium difficile Physiopathology in Response to Cysteine Availability. Infect Immun (2016) 0.77
A genetic switch controls the production of flagella and toxins in Clostridium difficile. PLoS Genet (2017) 0.75
Comparative genomic analysis of toxin-negative strains of Clostridium difficile from humans and animals with symptoms of gastrointestinal disease. BMC Microbiol (2016) 0.75
Inhibiting Microbial Toxins Using Plant-Derived Compounds and Plant Extracts. Medicines (Basel) (2015) 0.75
Clostridium difficile Colonizes Alternative Nutrient Niches during Infection across Distinct Murine Gut Microbiomes. mSystems (2017) 0.75
The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet (2006) 8.02
Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood (2008) 4.10
ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J Bacteriol (2007) 2.31
The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule. PLoS Pathog (2010) 2.28
Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. EMBO Rep (2009) 2.26
Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA. Proc Natl Acad Sci U S A (2010) 1.73
Environmental response and autoregulation of Clostridium difficile TxeR, a sigma factor for toxin gene expression. J Bacteriol (2002) 1.53
Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature (2016) 1.52
AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX. EMBO J (2010) 1.52
Peroxynitrite transforms nerve growth factor into an apoptotic factor for motor neurons. Free Radic Biol Med (2006) 1.50
Mycobacterial Ser/Thr protein kinases and phosphatases: physiological roles and therapeutic potential. Biochim Biophys Acta (2007) 1.49
Tethering of HP1 proteins to chromatin is relieved by phosphoacetylation of histone H3. EMBO Rep (2004) 1.48
FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI in humans and promotes IgE-induced lung inflammation. J Clin Invest (2008) 1.35
CcpA-mediated repression of Clostridium difficile toxin gene expression. Mol Microbiol (2010) 1.30
The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile. J Bacteriol (2011) 1.30
The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS Pathog (2011) 1.28
Revised nomenclature of Clostridium difficile toxins and associated genes. J Med Microbiol (2005) 1.28
Structural basis for the ABO blood-group dependence of Plasmodium falciparum rosetting. PLoS Pathog (2012) 1.27
Global transcriptional control by glucose and carbon regulator CcpA in Clostridium difficile. Nucleic Acids Res (2012) 1.25
Genome-wide identification of regulatory RNAs in the human pathogen Clostridium difficile. PLoS Genet (2013) 1.23
Structure of a Plasmodium falciparum PfEMP1 rosetting domain reveals a role for the N-terminal segment in heparin-mediated rosette inhibition. Proc Natl Acad Sci U S A (2011) 1.22
Reannotation of the genome sequence of Clostridium difficile strain 630. J Med Microbiol (2011) 1.18
A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients. Blood (2003) 1.17
Adaptive strategies and pathogenesis of Clostridium difficile from in vivo transcriptomics. Infect Immun (2013) 1.17
Organization and regulation of the neurotoxin genes in Clostridium botulinum and Clostridium tetani. Anaerobe (2004) 1.16
Cadherin-23, myosin VIIa and harmonin, encoded by Usher syndrome type I genes, form a ternary complex and interact with membrane phospholipids. Hum Mol Genet (2010) 1.14
The spore differentiation pathway in the enteric pathogen Clostridium difficile. PLoS Genet (2013) 1.14
Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: X-ray structure of Del1-9-G129R-hPRL. J Biol Chem (2007) 1.13
Secretion of Clostridium difficile toxins A and B requires the holin-like protein TcdE. PLoS Pathog (2012) 1.12
Genome-wide analysis of cell type-specific gene transcription during spore formation in Clostridium difficile. PLoS Genet (2013) 1.12
The spatial organization of the VirR boxes is critical for VirR-mediated expression of the perfringolysin O gene, pfoA, from Clostridium perfringens. J Bacteriol (2004) 1.11
Bacteriophage-mediated toxin gene regulation in Clostridium difficile. J Virol (2009) 1.09
Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med (2012) 1.08
A short synthetic peptide inhibits signal transduction, migration and angiogenesis mediated by Tie2 receptor. EMBO Rep (2004) 1.08
The structural basis of Arf effector specificity: the crystal structure of ARF6 in a complex with JIP4. EMBO J (2009) 1.07
BotR/A and TetR are alternative RNA polymerase sigma factors controlling the expression of the neurotoxin and associated protein genes in Clostridium botulinum type A and Clostridium tetani. Mol Microbiol (2005) 1.06
Crystal structure of an affinity-matured prolactin complexed to its dimerized receptor reveals the topology of hormone binding site 2. J Biol Chem (2010) 1.04
Citrullination of histone H3 interferes with HP1-mediated transcriptional repression. PLoS Genet (2012) 1.04
Structural characterization of the stem-stem dimerization interface between prolactin receptor chains complexed with the natural hormone. J Mol Biol (2010) 1.03
The high-affinity human IgG receptor FcγRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy. Blood (2013) 1.03
Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent Abeta-induced neurotoxicity and inhibit fibril formation. Mol Immunol (2008) 1.03
Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein. Sci Signal (2010) 1.01
The CymR regulator in complex with the enzyme CysK controls cysteine metabolism in Bacillus subtilis. J Biol Chem (2008) 1.01
Knowledge-based design of reagentless fluorescent biosensors from recombinant antibodies. J Mol Biol (2002) 1.00
Rabies virus matrix protein interplay with eIF3, new insights into rabies virus pathogenesis. Nucleic Acids Res (2007) 0.99
Expression of Clostridium difficile toxins A and B and their sigma factor TcdD is controlled by temperature. Infect Immun (2003) 0.96
Stable trimerization of recombinant rabies virus glycoprotein ectodomain is required for interaction with the p75NTR receptor. J Gen Virol (2005) 0.96
Insights into the Rrf2 repressor family--the structure of CymR, the global cysteine regulator of Bacillus subtilis. FEBS J (2011) 0.94
Calcium-induced folding and stabilization of the intrinsically disordered RTX domain of the CyaA toxin. Biophys J (2010) 0.91
Structural basis of myosin V Rab GTPase-dependent cargo recognition. Proc Natl Acad Sci U S A (2013) 0.91
A global benchmark study using affinity-based biosensors. Anal Biochem (2008) 0.91
Characterization of the elongasome core PBP2 : MreC complex of Helicobacter pylori. Mol Microbiol (2011) 0.91
Characterization of Acp, a peptidoglycan hydrolase of Clostridium perfringens with N-acetylglucosaminidase activity that is implicated in cell separation and stress-induced autolysis. J Bacteriol (2010) 0.91
Outer membrane targeting of secretin PulD protein relies on disordered domain recognition by a dedicated chaperone. J Biol Chem (2011) 0.89
Pilotin-secretin recognition in the type II secretion system of Klebsiella oxytoca. Mol Microbiol (2011) 0.87
Effects of subinhibitory concentrations of antibiotics on colonization factor expression by moxifloxacin-susceptible and moxifloxacin-resistant Clostridium difficile strains. Antimicrob Agents Chemother (2009) 0.87
Several regions of the repeat domain of the Staphylococcus caprae autolysin, AtlC, are involved in fibronectin binding. FEMS Microbiol Lett (2002) 0.87
Global regulation of gene expression in response to cysteine availability in Clostridium perfringens. BMC Microbiol (2010) 0.85
Inter- and intraspecies transfer of a Clostridium difficile conjugative transposon conferring resistance to MLSB. Microb Drug Resist (2014) 0.85
Diversity and junction residues as hotspots of binding energy in an antibody neutralizing the dengue virus. FEBS J (2006) 0.84
Molecular methods to study transcriptional regulation of Clostridium difficile toxin genes. Methods Mol Biol (2010) 0.83
Energetics of 5-bromo-4-chloro-3-indolyl-alpha-D-mannose binding to the Parkia platycephala seed lectin and its use for MAD phasing. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.83
Crl binds to domain 2 of σ(S) and confers a competitive advantage on a natural rpoS mutant of Salmonella enterica serovar Typhi. J Bacteriol (2010) 0.83
COV2HTML: a visualization and analysis tool of bacterial next generation sequencing (NGS) data for postgenomics life scientists. OMICS (2014) 0.83
Structural activation of the transcriptional repressor EthR from Mycobacterium tuberculosis by single amino acid change mimicking natural and synthetic ligands. Nucleic Acids Res (2011) 0.83
The scc spirochetal coiled-coil protein forms helix-like filaments and binds to nucleic acids generating nucleoprotein structures. J Bacteriol (2006) 0.83
Isolation of RNA polymerase from Clostridium difficile and characterization of glutamate dehydrogenase and rRNA gene promoters in vitro and in vivo. J Bacteriol (2006) 0.82
SUN proteins belong to a novel family of β-(1,3)-glucan-modifying enzymes involved in fungal morphogenesis. J Biol Chem (2013) 0.82
The LexA regulated genes of the Clostridium difficile. BMC Microbiol (2014) 0.80
Analysis of SUMOylated proteins using SUMO-traps. Sci Rep (2013) 0.80
The N-terminal domain of hepatocyte growth factor inhibits the angiogenic behavior of endothelial cells independently from binding to the c-met receptor. J Biol Chem (2003) 0.79
The α-helical regions of KERP1 are important in Entamoeba histolytica adherence to human cells. Sci Rep (2013) 0.79
Analysis of the Escherichia coli glucosamine-6-phosphate synthase activity by isothermal titration calorimetry and differential scanning calorimetry. Arch Biochem Biophys (2010) 0.78
Characterization of the non-native trifluoroethanol-induced intermediate conformational state of the Shiga toxin B-subunit. Biochimie (2006) 0.77
Hydrodynamic characterization of recombinant human fibrinogen species. Thromb Res (2013) 0.77
Structural and functional features of Crl proteins and identification of conserved surface residues required for interaction with the RpoS/σS subunit of RNA polymerase. Biochem J (2014) 0.77
Erratum: Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature (2016) 0.76
Correction: The Translocation Domain of Botulinum Neurotoxin A Moderates the Propensity of the Catalytic Domain to Interact with Membranes at Acidic pH. PLoS One (2016) 0.75
Harnessing malE for the study of antigen/antibody recognitions. Res Microbiol (2002) 0.75
Novel svVEGF isoforms from Macrovipera lebetina venom interact with neuropilins. Biochem Biophys Res Commun (2009) 0.75
Erratum: High affinity anchoring of the decoration protein pb10 onto the bacteriophage T5 capsid. Sci Rep (2017) 0.75